Treatment BPH
ProcedureWe compare 3 different types of BPH surgery - HoLEP vs. TURP vs. REZUM
NCT Number: NCT07204002
Benign prostatic enlargement (BPH/BPS) is one of the most common benign diseases in adult men. About 50% of men are affected by the age of 50, and between the ages of 70 and 80 the prevalence rises to 70-80%.
There are various surgical procedures available for the treatment of BPH. In this study, we are investigating three surgical procedures which, based on the current data, appear to be relatively equivalent; however, additional data are still needed to substantiate this.
The aim of this study is to compare the three surgical methods REZUM vs. HoLEP vs. TUR-P for endoscopic transurethral subvesical de-obstruction with regard to both subjective and objective voiding function, as well as improvements in quality of life and sexual function.
The goal of the study is to work out the possible advantages and disadvantages for future patient counseling, thereby defining more precisely the role of these surgical procedures within the armamentarium of urology. This is a single-center, randomized, prospective interventional study.
Trial opening soon.
Get Notified18 year and older
Male
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lack of capacity to give informed consent
We compare 3 different types of BPH surgery - HoLEP vs. TURP vs. REZUM
Time frame: 1 month
Contact information is provided by the study sponsor or research team.
Medical University of Graz
Other
Acronym: Vektor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07456345
BPH (Benign Prostatic Hyperplasia), Female Urogenital Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT06901115
BPH (Benign Prostatic Hyperplasia), Genital Diseases
Shebin El-Kom, Menoufia, Egypt
View Trial DetailsNCT06753071
BPH (Benign Prostatic Hyperplasia), Female Urogenital Diseases
Shebin El-Kom, Menoufia, Egypt
View Trial DetailsNCT07728071
BPH (Benign Prostatic Hyperplasia), Genital Diseases
Shatin, Hong Kong
View Trial Details